Financhill
Buy
62

CL Quote, Financials, Valuation and Earnings

Last price:
$79.95
Seasonality move :
2.88%
Day range:
$77.77 - $79.07
52-week range:
$74.55 - $100.18
Dividend yield:
2.61%
P/E ratio:
22.15x
P/S ratio:
3.20x
P/B ratio:
74.43x
Volume:
5.2M
Avg. volume:
6.4M
1-year change:
-14.12%
Market cap:
$63.7B
Revenue:
$20.1B
EPS (TTM):
$3.57
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $16.5B $17.4B $18B $19.5B $20.1B
Revenue Growth (YoY) 4.96% 5.77% 3.13% 8.29% 3.31%
 
Cost of Revenues $6.5B $7.1B $7.8B $8.2B $8B
Gross Profit $9.9B $10.3B $10.2B $11.3B $12.1B
Gross Profit Margin 60.31% 59.08% 56.49% 57.83% 60.23%
 
R&D Expenses $290M $307M $320M $343M $355M
Selling, General & Admin $6B $6.4B $6.6B $7.2B $7.7B
Other Inc / (Exp) -$64M -$723M -$804M -$461M -$149M
Operating Expenses $6B $6.4B $6.6B $7.1B $7.7B
Operating Income $3.9B $3.9B $3.6B $4.1B $4.4B
 
Net Interest Expenses $160M $117M $167M $287M $292M
EBT. Incl. Unusual Items $3.6B $3.1B $2.7B $3.4B $4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $787M $749M $693M $937M $907M
Net Income to Company $2.9B $2.3B $2B $2.5B $3B
 
Minority Interest in Earnings $165M $172M $182M $155M $160M
Net Income to Common Excl Extra Items $2.9B $2.3B $2B $2.5B $3B
 
Basic EPS (Cont. Ops) $3.15 $2.56 $2.13 $2.78 $3.53
Diluted EPS (Cont. Ops) $3.14 $2.55 $2.13 $2.77 $3.51
Weighted Average Basic Share $856.8M $845M $836.4M $827.4M $819.1M
Weighted Average Diluted Share $859.3M $848.3M $838.8M $829.2M $823.2M
 
EBITDA $4.5B $4.4B $4.1B $4.7B $5B
EBIT $3.9B $3.9B $3.6B $4.1B $4.4B
 
Revenue (Reported) $16.5B $17.4B $18B $19.5B $20.1B
Operating Income (Reported) $3.9B $3.9B $3.6B $4.1B $4.4B
Operating Income (Adjusted) $3.9B $3.9B $3.6B $4.1B $4.4B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $4.4B $4.5B $4.9B $5B $5.1B
Revenue Growth (YoY) 6.29% 0.93% 10.33% 2.4% 1.95%
 
Cost of Revenues $1.8B $1.9B $2B $2B $2.1B
Gross Profit $2.6B $2.5B $2.9B $3.1B $3B
Gross Profit Margin 59.47% 57.1% 58.66% 61.08% 59.42%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.6B $1.6B $1.8B $2B $2B
Other Inc / (Exp) -$16M -$15M -$15M -$23M --
Operating Expenses $1.6B $1.6B $1.8B $2B $2B
Operating Income $989M $913M $1.1B $1.1B $1.1B
 
Net Interest Expenses $98M $40M $60M $56M $67M
EBT. Incl. Unusual Items $853M $892M $956M $986M $992M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $172M $210M $209M $210M $226M
Net Income to Company $681M $682M $747M $775M $767M
 
Minority Interest in Earnings $47M $64M $39M $39M $31M
Net Income to Common Excl Extra Items $681M $682M $747M $776M $766M
 
Basic EPS (Cont. Ops) $0.75 $0.74 $0.86 $0.90 $0.91
Diluted EPS (Cont. Ops) $0.75 $0.74 $0.86 $0.90 $0.91
Weighted Average Basic Share $843.6M $835.7M $825.6M $817.7M $807.8M
Weighted Average Diluted Share $846.4M $838.5M $827.3M $822.5M $810.2M
 
EBITDA $1.1B $1B $1.2B $1.3B $1.3B
EBIT $989M $913M $1.1B $1.1B $1.1B
 
Revenue (Reported) $4.4B $4.5B $4.9B $5B $5.1B
Operating Income (Reported) $989M $913M $1.1B $1.1B $1.1B
Operating Income (Adjusted) $989M $913M $1.1B $1.1B $1.1B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $17.3B $17.7B $19.1B $20.1B $20.1B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $6.9B $7.5B $8.2B $8B $8B
Gross Profit $10.5B $10.2B $11B $12.1B $12.1B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $6.4B $6.5B $7B $7.6B $7.7B
Other Inc / (Exp) -$60M -$736M -$1.1B -$190M --
Operating Expenses $6.4B $6.5B $7B $7.6B $7.7B
Operating Income $4B $3.8B $4B $4.6B $4.4B
 
Net Interest Expenses $186M $121M $227M $238M $270M
EBT. Incl. Unusual Items $3.7B $2.9B $2.5B $4B $3.9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $815M $740M $798M $919M $902M
Net Income to Company $2.8B $2.1B $1.7B $3B $3B
 
Minority Interest in Earnings $177M $184M $151M $163M $137M
Net Income to Common Excl Extra Items $2.8B $2.1B $1.7B $3B $3B
 
Basic EPS (Cont. Ops) $3.14 $2.30 $1.92 $3.50 $3.58
Diluted EPS (Cont. Ops) $3.13 $2.29 $1.91 $3.48 $3.57
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $4.6B $4.3B $4.5B $5.2B $5B
EBIT $4B $3.8B $4B $4.6B $4.4B
 
Revenue (Reported) $17.3B $17.7B $19.1B $20.1B $20.1B
Operating Income (Reported) $4B $3.8B $4B $4.6B $4.4B
Operating Income (Adjusted) $4B $3.8B $4B $4.6B $4.4B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $13B $13.3B $14.5B $15.2B $15.2B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $5.2B $5.7B $6.1B $6B $6B
Gross Profit $7.8B $7.7B $8.4B $9.2B $9.1B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $4.8B $4.9B $5.3B $5.8B $5.8B
Other Inc / (Exp) -$52M -$65M -$338M -$67M -$95M
Operating Expenses $4.8B $4.9B $5.3B $5.8B $5.8B
Operating Income $3B $2.8B $3.1B $3.4B $3.3B
 
Net Interest Expenses $152M $98M $172M $176M $204M
EBT. Incl. Unusual Items $2.8B $2.5B $2.4B $3B $3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $613M $604M $709M $691M $687M
Net Income to Company $2.2B $1.9B $1.7B $2.3B $2.3B
 
Minority Interest in Earnings $132M $144M $113M $121M $97M
Net Income to Common Excl Extra Items $2.2B $1.9B $1.7B $2.3B $2.3B
 
Basic EPS (Cont. Ops) $2.39 $2.13 $1.91 $2.62 $2.68
Diluted EPS (Cont. Ops) $2.38 $2.12 $1.91 $2.61 $2.67
Weighted Average Basic Share $2.5B $2.5B $2.5B $2.5B $2.4B
Weighted Average Diluted Share $2.5B $2.5B $2.5B $2.5B $2.4B
 
EBITDA $3.4B $3.2B $3.5B $3.9B $3.8B
EBIT $3B $2.8B $3.1B $3.4B $3.3B
 
Revenue (Reported) $13B $13.3B $14.5B $15.2B $15.2B
Operating Income (Reported) $3B $2.8B $3.1B $3.4B $3.3B
Operating Income (Adjusted) $3B $2.8B $3.1B $3.4B $3.3B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $925M $866M $950M $1.1B $1.3B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.3B $1.3B $1.5B $1.6B $1.5B
Inventory $1.7B $1.7B $2.1B $1.9B $2B
Prepaid Expenses -- -- -- -- $520M
Other Current Assets $513M $576M $760M $793M $713M
Total Current Assets $4.3B $4.4B $5.1B $5.3B $5.3B
 
Property Plant And Equipment $4.2B $4.3B $4.8B $5.1B $5B
Long-Term Investments $85M $84M $70M $83M $81M
Goodwill $3.8B $3.3B $3.4B $3.4B $3.3B
Other Intangibles $2.9B $2.5B $1.9B $1.9B $1.8B
Other Long-Term Assets $857M $974M $904M $1B $1.1B
Total Assets $15.9B $15B $15.7B $16.4B $16B
 
Accounts Payable $1.4B $1.5B $1.6B $1.7B $1.8B
Accrued Expenses $1.9B $1.7B $1.8B $2B $2.1B
Current Portion Of Long-Term Debt $267M $51M $25M $330M $660M
Current Portion Of Capital Lease Obligations $137M $137M $108M $95M $107M
Other Current Liabilities $93M $6M $15M $26M $23M
Total Current Liabilities $4.4B $4.1B $4B $4.7B $5.8B
 
Long-Term Debt $7.8B $7.6B $9.1B $8.6B $7.7B
Capital Leases -- -- -- -- --
Total Liabilities $14.8B $14.1B $14.9B $15.4B $15.5B
 
Common Stock $1.5B $1.5B $1.5B $1.5B $1.5B
Other Common Equity Adj -$4.3B -$4.4B -$4.1B -$3.9B -$4.2B
Common Equity $743M $609M $401M $609M $212M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $358M $362M $405M $348M $332M
Total Equity $1.1B $971M $806M $957M $544M
 
Total Liabilities and Equity $15.9B $15B $15.7B $16.4B $16B
Cash and Short Terms $925M $866M $950M $1.1B $1.3B
Total Debt $8.2B $7.7B $9.2B $8.7B $8.4B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Cash and Equivalents $1.1B $1.1B $1.2B $1.5B $1.5B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.4B $1.4B $1.6B $1.7B $1.8B
Inventory $1.7B $2.1B $1.9B $2B $2.1B
Prepaid Expenses -- -- -- -- --
Other Current Assets $618M $842M $898M $819M --
Total Current Assets $4.7B $5.3B $5.4B $5.8B $6B
 
Property Plant And Equipment $3.6B $4.1B $4.4B $4.4B $4.6B
Long-Term Investments -- -- -- -- --
Goodwill $3.7B $3.5B $3.3B $3.4B --
Other Intangibles $2.7B $2.2B $1.9B $1.8B --
Other Long-Term Assets $913M $948M $887M $1.1B --
Total Assets $15.9B $16.3B $16B $16.8B $17.5B
 
Accounts Payable $1.3B $1.5B $1.5B $1.6B $1.9B
Accrued Expenses $2.6B $2.5B $2.7B $3.1B --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $4.3B $4.5B $4.6B $5.6B $6.5B
 
Long-Term Debt $7.7B $8.2B $8.7B $7.9B $7.3B
Capital Leases -- -- -- -- --
Total Liabilities $14.9B $15.2B $15.6B $15.9B $16.3B
 
Common Stock $1.5B $1.5B $1.5B $1.5B $1.5B
Other Common Equity Adj -$4.4B -$4.2B -$4B -$4.1B --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $436M $431M $415M $401M $382M
Total Equity $1B $1.1B $406M $836M $1.2B
 
Total Liabilities and Equity $15.9B $16.3B $16B $16.8B $17.5B
Cash and Short Terms $1.1B $1.1B $1.2B $1.5B $1.5B
Total Debt $7.7B $8.2B $8.7B $7.9B $8.4B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $2.9B $2.3B $2B $2.5B $3B
Depreciation & Amoritzation $539M $556M $545M $567M $605M
Stock-Based Compensation $107M $135M $125M $122M $135M
Change in Accounts Receivable $138M -$84M -$227M -$37M -$56M
Change in Inventories -$251M -$72M -$333M $194M -$100M
Cash From Operations $3.7B $3.3B $2.6B $3.7B $4.1B
 
Capital Expenditures $410M $567M $696M $705M $561M
Cash Acquisitions $452M -- $809M -- --
Cash From Investing -$878M -$592M -$1.6B -$742M -$534M
 
Dividends Paid (Ex Special Dividend) $1.5B $1.5B $1.6B $1.6B $1.6B
Special Dividend Paid
Long-Term Debt Issued -- $699M $1.5B $1.5B $2M
Long-Term Debt Repaid -$1.1B -$703M -$406M -$903M -$503M
Repurchase of Common Stock $1.5B $1.3B $1.3B $1.1B $1.7B
Other Financing Activities -$66M -$24M -$18M $18M -$91M
Cash From Financing -$2.8B -$2.8B -$952M -$2.8B -$3.4B
 
Beginning Cash (CF) $888M $832M $775M $966M $1.1B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $5M -$56M -$57M $191M $130M
Ending Cash (CF) $877M $761M $658M $1.1B $1.2B
 
Levered Free Cash Flow $3.3B $2.8B $1.9B $3B $3.5B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $681M $682M $747M $775M $767M
Depreciation & Amoritzation $140M $134M $144M $150M $158M
Stock-Based Compensation $49M $60M $60M $65M $72M
Change in Accounts Receivable -$10M $20M $50M $125M -$28M
Change in Inventories $2M -$90M $96M -$77M $6M
Cash From Operations $994M $969M $1.2B $1.2B $1.3B
 
Capital Expenditures $137M $175M $161M $134M $155M
Cash Acquisitions -- $727M -- -- --
Cash From Investing -$173M -$946M -$161M -$150M -$154M
 
Dividends Paid (Ex Special Dividend) $387M $392M $396M $408M $420M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $94M $1.5B -- -- --
Long-Term Debt Repaid -$118M -$2M -- -$2M --
Repurchase of Common Stock $251M $104M $332M $295M $288M
Other Financing Activities -$7M -$20M -$35M $44M --
Cash From Financing -$784M $99M -$846M -$904M -$1B
 
Beginning Cash (CF) $958M $938M $951M $1.2B $1.3B
Foreign Exchange Rate Adjustment -$16M -$42M -$13M $11M -$15M
Additions / Reductions $21M $80M $132M $124M $64M
Ending Cash (CF) $963M $976M $1.1B $1.4B $1.3B
 
Levered Free Cash Flow $857M $794M $991M $1B $1.1B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $2.8B $2.1B $1.7B $3B $3B
Depreciation & Amoritzation $553M $552M $552M $607M $605M
Stock-Based Compensation $129M $133M $117M $133M $154M
Change in Accounts Receivable -$122M -$57M -$118M -$159M -$52M
Change in Inventories -$74M -$457M $239M -$50M $3M
Cash From Operations $3.2B $3B $3.3B $4B $4B
 
Capital Expenditures $535M $668M $729M $574M $571M
Cash Acquisitions $1M $817M -$8M -- $293M
Cash From Investing -$573M -$1.6B -$772M -$597M -$794M
 
Dividends Paid (Ex Special Dividend) $1.5B $1.5B $1.6B $1.6B $1.6B
Special Dividend Paid
Long-Term Debt Issued $119M $2.1B $1.5B -- --
Long-Term Debt Repaid -- -$587M -$1.3B -$502M --
Repurchase of Common Stock $1.9B $1.3B $1.3B $1.5B $1.3B
Other Financing Activities -$10M -$53M -$10M $49M --
Cash From Financing -$2.6B -$1.4B -$2.5B -$3.1B -$3.2B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$31M -$20M $13M $283M $45M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $2.6B $2.3B $2.6B $3.4B $3.4B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $2.2B $1.9B $1.7B $2.3B $2.3B
Depreciation & Amoritzation $414M $410M $417M $457M $457M
Stock-Based Compensation $107M $105M $97M $108M $127M
Change in Accounts Receivable -$198M -$171M -$62M -$184M -$180M
Change in Inventories -$37M -$422M $150M -$94M $9M
Cash From Operations $2.2B $1.9B $2.6B $2.8B $2.7B
 
Capital Expenditures $374M $475M $508M $377M $387M
Cash Acquisitions -- $817M -- -- $293M
Cash From Investing -$462M -$1.4B -$599M -$454M -$714M
 
Dividends Paid (Ex Special Dividend) $1.2B $1.2B $1.2B $1.3B $1.3B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $119M $1.5B $1.5B $2M $497M
Long-Term Debt Repaid -$118M -$2M -$903M -$502M -$139M
Repurchase of Common Stock $964M $895M $883M $1.3B $804M
Other Financing Activities -$9M -$38M -$30M $1M $136M
Cash From Financing -$1.7B -$286M -$1.8B -$2.1B -$1.9B
 
Beginning Cash (CF) $2.9B $2.7B $2.6B $3.4B $3.6B
Foreign Exchange Rate Adjustment -$19M -$63M -$33M -$6M $47M
Additions / Reductions $70M $106M $176M $268M $183M
Ending Cash (CF) $2.9B $2.7B $2.8B $3.7B $3.8B
 
Levered Free Cash Flow $1.8B $1.4B $2.1B $2.5B $2.4B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Is Berkshire Hathaway Stock Undervalued?
Is Berkshire Hathaway Stock Undervalued?

Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…

Is Oracle Stock Undervalued?
Is Oracle Stock Undervalued?

Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 23

Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.

Buy
52
ABVX alert for Dec 23

Abivax SA [ABVX] is down 0.27% over the past day.

Buy
60
ZBIO alert for Dec 23

Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock